Is The Santa Claus Rally The Gift That Keeps Giving?
Remember the horror of 2008 when the Great Recession hit…
Sell
42
XCUR Quote, Financials, Valuation and Earnings
Last price:
$16.87
Seasonality move
:
3.88%
Day range:
$16.53 - $20.00
52-week range:
$1.44 - $36.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
24.16x
Volume:
63.9K
Avg. volume:
1.4M
1-year change:
448.01%
Market cap:
$37.3M
Revenue:
--
EPS (TTM):
-$2.08
Analysts' Opinion
-
Consensus RatingExicure has received a consensus rating of --. The company's average rating is a -- based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of --, Exicure has an estimated downside of -41.79% from its current price of $17.18.
-
Price Target UpsideAccording to analysts, the highest upside price target is -- representing -100% upside increase from its current price of $17.18.
Fair Value
-
According to the consensus of 0 analysts, Exicure has -41.79% downside to fair value with a price target of -- per share.
XCUR vs. S&P 500
-
Over the past 5 trading days, Exicure has underperformed the S&P 500 by -9.94% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Exicure does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Exicure has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Exicure reported revenues of $500K.
Earnings Growth
-
Exicure has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Exicure reported earnings per share of -$0.57.
Enterprise value:
37M
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
-12.83x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
-86.89%
Net Income Margin (TTM):
--
Return On Equity:
-195.77%
Return On Invested Capital:
-195.77%
Operating Margin:
-167.2%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $9.2M | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -$33.9M | $6M | -$5M | -$2.4M | -$1.4M | |
| EBITDA | -$32M | $4.7M | -$3.2M | -$4.9M | -$863K | |
| Diluted EPS | -$46.65 | $10.56 | -$2.08 | -$3.04 | -$0.57 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $96.8M | $64.1M | $17.2M | $3.1M | $2.6M | |
| Total Assets | $111.3M | $77.9M | $28.9M | $13M | $10.6M | |
| Current Liabilities | $12.6M | $22M | $25.7M | $2.2M | $3.7M | |
| Total Liabilities | $37.9M | $63.9M | $32.6M | $8.5M | $9.1M | |
| Total Equity | $73.4M | $14M | -$3.7M | $4.5M | $1.5M | |
| Total Debt | $16.5M | $16.8M | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$42.2M | -$16.8M | -$2.9M | -$1.4M | -$449K | |
| Cash From Investing | $8.6M | -$1.6M | $711K | -- | -- | |
| Cash From Financing | -$2.7M | $3.7M | $999K | -$1K | -- | |
| Free Cash Flow | -$42.5M | -$16.8M | -$2.9M | -$1.4M | -$449K | |
XCUR
Sector
Market Cap
$37.3M
$46.1M
Price % of 52-Week High
47.72%
46.02%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.6%
1-Year Price Total Return
448.01%
-30.52%
Beta (5-Year)
3.664
0.772
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$17.76
200-day SMA
Buy
Level
$4.57
Bollinger Bands (100)
Buy
Level
-1.09 - 14.65
Chaikin Money Flow
Sell
Level
-467.5M
20-day SMA
Sell
Level
$20.60
Relative Strength Index (RSI14)
Buy
Level
51.07
ADX Line
Buy
Level
10.47
Williams %R
Neutral
Level
-77.9786
50-day SMA
Buy
Level
$11.09
MACD (12, 26)
Buy
Level
1.52
25-day Aroon Oscillator
Buy
Level
24
On Balance Volume
Neutral
Level
540.4M
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
--
CA Score
(Annual)
Level (--)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (3)
--
Ohlson Score
Level (--)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Sell
Fundamental Score
Level (1)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Exicure Inc is a biotechnology company that develops nucleic acid therapies targeting ribonucleic acid against validated targets for neurological disorders and hair loss. It operates in a single segment, which is the discovery, research, and development of treatments based on its SNA (Spherical Nucleic Acid) technology.
Stock Forecast FAQ
In the current month, XCUR has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The XCUR average analyst price target in the past 3 months is --.
-
Where Will Exicure Stock Be In 1 Year?
According to analysts, the consensus estimate is that Exicure share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Exicure?
Analysts are divided on their view about Exicure share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Exicure is a Sell and believe this share price will rise from its current level to --.
-
What Is Exicure's Price Target?
The price target for Exicure over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is XCUR A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Exicure is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of XCUR?
You can purchase shares of Exicure via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Exicure shares.
-
What Is The Exicure Share Price Today?
Exicure was last trading at $16.87 per share. This represents the most recent stock quote for Exicure. Yesterday, Exicure closed at $17.18 per share.
-
How To Buy Exicure Stock Online?
In order to purchase Exicure stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Alphabet an Undervalued Growth Stock to Buy?
Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…
Is Tesla Going to Buy Uber?
Tesla has always been in the habit of making large,…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 118x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
87
PSIX alert for Dec 25
Power Solutions International [PSIX] is up 27.42% over the past day.
Buy
65
TSLL alert for Dec 25
Direxion Daily TSLA Bull 2X Shares [TSLL] is up 19.46% over the past day.
Buy
75
SMLR alert for Dec 25
Semler Scientific [SMLR] is up 15.37% over the past day.
